Donald Marvin serves as Executive at Chemomab Therapeutics Ltd., where they oversee executive responsibilities. Since joining the company, Donald Marvin has executed 7 insider transactions totaling $6.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 16, 2022 involved purchasing 250 shares valued at $813.
Donald Marvin currently holds 2,000 shares of Chemomab Therapeutics Ltd. (CMMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donald Marvin has been a net buyer of CMMB stock. They have purchased $6.7K and sold $0 worth of shares.
Donald Marvin's most recent insider trade was on Mar 16, 2022, when they purchased 250 shares at $3.25 per share.
Get notified when new Form 4 filings are submitted
| $3.30 |
| Discretionary |
| Mar 14, 2022 | CMMB | $995 | Purchase | 250 | $3.98 | Discretionary |
| Mar 14, 2022 | CMMB | $1.0K | Purchase | 250 | $4.00 | Discretionary |
| Mar 14, 2022 | CMMB | $1.1K | Purchase | 250 | $4.20 | Discretionary |
| Mar 14, 2022 | CMMB | $1.0K | Purchase | 250 | $4.10 | Discretionary |
| Mar 14, 2022 | CMMB | $975 | Purchase | 250 | $3.90 | Discretionary |